Showing results (91-100 of 106) with videos related to
Sort By:
Pageof 11
European Urology|December 26, 2001
Frequent p16/MTS1 inactivation in early stages of urothelial carcinoma of the bladder is not associated with tumor recurrenceM G Friedrich, C Blind, K Milde-Langosch, et al.Urology|March 15, 2001
Significance of high-grade prostatic intraepithelial neoplasia in needle biopsy specimensW Prange, A Erbersdobler, P Hammerer, et al.Der Urologe. Ausg. A|March 11, 2017
[Use of the S3 guidelines for early detection of prostate cancer in urological practices]D Tiedje, O Quer, B Breil, et al.Virchows Archiv : an International Journal of Pathology|June 16, 2001
Flow cytometric DNA and phenotype analysis in pathology. A meeting report of a symposium at the annual conference of the German Society of Pathology, Kiel, Germany, 6-9 June 2000M Nap, G Brockhoff, B Brandt, et al.World Journal of Urology|February 28, 2020
68Ga-PSMA PET/CT based primary staging and histological correlation after extended pelvic lymph node dissection at radical prostatectomyJ Kopp, D Kopp, E Bernhardt, et al.European Urology|June 12, 1999
Early prostate-specific antigen relapse after radical retropubic prostatectomy: prediction on the basis of preoperative and postoperative tumor characteristicsM Graefen, J Noldus, U Pichlmeier, et al.Der Urologe. Ausg. A|February 9, 2000
[Prognostic markers for prostate cancer]M Graefen, P Hammerer, J Noldus, et al.Cancer Research|February 24, 2001
Cytogenetic analysis of multifocal bladder cancer supports a monoclonal origin and intraepithelial spread of tumor cellsR Simon, E Eltze, K L Schäfer, et al.International Journal of Clinical Practice|May 27, 2004
Management of prostate-specific antigen relapse in prostate cancer: a European ConsensusL Boccon-Gibod, W B Djavan, P Hammerer, et al.Aktuelle Urologie|July 27, 2013
[Value of intermittent androgen deprivation in the context of the current data situation]K Miller, P Hammerer, R Eichenauer, et al.Pageof 11